This webinar is a collaboration between the USC Price School of Public Policy and the Schaeffer Center for Health Policy & Economics.
For decades, the high cost of college has limited access to many while sending others into significant debt. Now, as COVID-19 forces many schools to a virtual teaching format, college administrators are finding their costs are soaring while revenues fall. State schools face lower tax-dollar support while many small private schools may not survive. Amid all this uncertainty, technology has emerged as a definite primary ingredient of higher education in the future.
How will COVID-19 permanently reshape the landscape? Join USC Price School Interim Dean and USC Schaeffer Center Director Dana Goldman in conversation with Raynard Kington, an expert in education and health policy, on September 24 for a wide-ranging discussion about the future of higher education. Kington is the former president of Grinnell College and former principal deputy director of the National Institutes of Health.
- Event Date
- Thursday, September 24, 2020
1:30 PM - 2:15 PM Pacific
Dr. Raynard S. Kington began his work as Head of School at Phillips Academy in Andover, Massachusetts, in July 2020. Prior to coming to Andover, he served for ten years as President of Grinnell College (2010-2020) and previously in a range of positions at the National Institutes of Health (NIH), including NIH Principal Deputy Director and NIH Acting Director, NIH Associate Director for Behavioral and Social Sciences Research, and Acting Director of the National Institute on Alcohol Abuse and Alcoholism. Before NIH he was a division director at the Centers for Disease Control and Prevention and served as Director of the National Health and Nutrition Examination Survey (NHANES). He has also been a Senior Scientist at the RAND Corporation and an Assistant Professor of Medicine at UCLA. He was elected to the Institute of Medicine (now, the National Academy of Medicine – NAM) in 2006. Dr. Kington attended the University of Michigan, where he received both his B.S. with distinction and his M.D. and completed his residency in Internal Medicine at Michael Reese Medical Center in Chicago. He was a Robert Wood Johnson Clinical Scholar at the University of Pennsylvania where he completed his M.B.A. with distinction and his Ph.D. with a concentration in Health Policy and Economics at the Wharton School and was awarded a Fontaine Fellowship. He received his board certification in Internal Medicine, Public Health and Preventive Medicine, and Geriatric Medicine. His research has focused on the social determinants of health and more recently on diversity in the scientific workforce.
Dana Goldman, PhD
Interim Dean, USC Price School
Director, USC Schaeffer Center
Distinguished Professor of Public Policy, Pharmacy & Economics, USC School of Pharmacy and the USC Price School of Public Policy
Dana Goldman, PhD, is the Leonard D. Schaeffer Chair and a Distinguished Professor of Pharmacy, Public Policy, and Economics at the University of Southern California. He also directs the USC Schaeffer Center for Health Policy and Economics, a research hub for one of the nation’s premier health policy and management programs in the Sol Price School of Public Policy and School of Pharmacy.
Goldman is the author of approximately 250 articles and book chapters in medicine, health policy, economics, and statistics. He has served—or is serving—as a health policy advisor to the Congressional Budget Office, Covered California (the California insurance exchange), and the Fred Hutchinson Cancer Institute’s Outcomes Research External Advisory Board. He is a founding editor of the Forum for Health Economics and Policy, and serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He is a former director of the International Society for Pharmacoeconomics and Outcomes Research and the American Society of Health Economists. Goldman's work has been featured in The New York Times, The Wall Street Journal, Forbes, The Washington Post, Business Week, U.S. News and World Report, The Economist, NBC Nightly News, CNN, National Public Radio, and other media.
Goldman is an elected member of the National Academy of Medicine and the National Academy of Social Insurance. In 2016, he was appointed a Distinguished Professor at the University of Southern California in honor of accomplishments that have brought the University special renown. He is a past recipient of the MetLife Foundation Silver Scholar Award, honoring his research to define the value of healthy aging and medical innovations to help individuals live healthier and longer lives; the Eugene Garfield Economic Impact Prize, recognizing outstanding research demonstrating how medical research impacts the economy; the National Institute for Health Care Management Research Foundation award for excellence in health policy; and the Alice S. Hersh New Investigator Award recognizing contributions of a young scholar to health services research.
Goldman is also an Adjunct Professor of Health Services at UCLA and a research associate with the National Bureau of Economic Research. He was a co-founder of Precision Health Economics, a consultancy that provides services to health insurance, pharmaceutical, biological and health care technology companies, and he currently serves as a consultant to the firm. He serves on a scientific advisory board to ACADIA Pharmaceuticals. Prior to arriving at USC, he spent 15 years at the RAND Corporation, where he held the Distinguished Chair in Health Economics and served as director of RAND's program in Health Economics, Finance, and Organization and the Bing Center for Health Economics.
Goldman received his BA summa cum laude from Cornell University and a PhD in Economics from Stanford University.